Unbiased metagenomics sequencing allows the detection of any potential pathogen in a sample using a single methodology. This technique has been used to successfully identify pathogens in case reports of patients with central nervous system (CNS) infection. Metagenomics sequencing also provides genomic information that can be used to classify pathogens and perform studies of molecular epidemiology, especially for viruses, which have small genomes amenable to full-genome sequencing. Here, we apply metagenomics sequencing to detect and sequence viruses in a prospective cohort of patients with CNS infection. We enroll patients with both known (control) and unknown or suspected CNS infection and obtain samples of cerebrospinal fluid. We perform unbiased library construction from both RNA and DNA, followed by deep sequencing and metagenomics analysis. In patients with known infections, we have successfully sequenced Herpes Simplex Virus (HSV)-1 in two cases and HSV-2 in one case, obtaining partial genomes that allowed species classification. We have also successfully sequenced enterovirus in two cases, obtaining full-length viral genomes that allowed strain classification and phylogenetic analysis. In one patient with unknown infection, we identified Powassan virus, an emerging tick-borne flavivirus that causes encephalitis in the Northeastern United States. In that case, our NGS results were obtained three weeks earlier than routine clinical testing by serology, highlighting the potential application of this method for rapid diagnosis of infection. As work in progress, we are currently sequencing the full viral genome, which will be the first Powassan virus genome sequenced directly from a clinical sample. This will allow phylogenetic comparison to genomes isolated from tick vectors in order to assess whether there are viral characteristics associated with human infection. Overall, our results highlight the utility of metagenomics NGS to identify and study the molecular epidemiology of viruses that cause CNS infection.
